Abstract
The identification of novel biomarkers in cancer patients often requires both survival and gene expression analyses. The Kaplan–Meier survival analysis is one of the most common methods to assess the fraction of subjects living for a certain amount of time.
Here, we describe a method for researchers to identify potential prognostic markers across distinct tumor types. We utilize The Cancer Genome Atlas (TCGA) as this is one of the most extensive and successful cancer genomics programs to date that includes expression data and clinical follow-up information for up to 33 distinct tumor types. Nevertheless, the method described here can also be applied to any open-source dataset where the RNA expression and clinical outcome are provided.
We provide detailed practical instructions and advices for investigators to be able to successfully identify prognostic markers in cancer patients.
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Similar content being viewed by others
References
Yang Y, Klionsky DJ (2020) Autophagy and disease: unanswered questions. Cell Death Differ 27:858–871. https://doi.org/10.1038/s41418-019-0480-9
Guo JY, White E (2016) Autophagy, metabolism, and cancer. Cold Spring Harb Symp Quant Biol 81:73–78. https://doi.org/10.1101/sqb.2016.81.030981
Zhang B, Zheng A, Hydbring P, Ambroise G, Ouchida AT, Goiny M, Vakifahmetoglu-Norberg H, Norberg E (2017) PHGDH defines a metabolic subtype in lung adenocarcinomas with poor prognosis. Cell Rep 19(11):2289–2303. https://doi.org/10.1016/j.celrep.2017.05.067
Ambroise G, Yu TT, Zhang B, Kacal M, Hao Y, Queiroz AL, Ouchida AT, Lindskog C, Norberg E, Vakifahmetoglu-Norberg H (2020) Systematic analysis reveals a functional role for stambpl1 in the epithelial-mesenchymal transition process across multiple carcinomas. Br J Cancer 123:1164–1177. https://doi.org/10.1038/s41416-020-0972-x
Krassikova L, Zhang B, Nagarajan D, Queiroz AL, Kacal M, Samakidis E, Vakifahmetoglu-Norberg H, Norberg E (2021) The deubiquitinase JOSD2 is a positive regulator of glucose metabolism. Cell Death Differ 28(3):1091–1109. https://doi.org/10.1038/s41418-020-00639-1
Dobin A, Davis CA, Schlesinger F, Drenkow J, Zaleski C, Jha S, Batut P, Chaisson M, Gingeras TR (2013) Star: Ultrafast universal rna-seq aligner. Bioinformatics 29:15–21. https://doi.org/10.1093/bioinformatics/bts635
Anders S, Pyl PT, Huber W (2015) Htseq--a python framework to work with high-throughput sequencing data. Bioinformatics 31:166–169. https://doi.org/10.1093/bioinformatics/btu638
Acknowledgments
This work was supported by grants from The Swedish Cancer Society (Cancerfonden), The Swedish Research Council (VR), Karolinska Institute Tenure Track Research grants, Wenner-Gren Foundation, and Stiftelsen Längmanska Kulturfonden.
Author information
Authors and Affiliations
Corresponding author
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2022 The Author(s), under exclusive license to Springer Science+Business Media, LLC, part of Springer Nature
About this protocol
Cite this protocol
Zhang, B., Kochetkova, E., Norberg, E. (2022). A Method to Identify Potential Prognostic Markers Across Distinct Tumor Types. In: Norberg, H., Norberg, E. (eds) Autophagy and Cancer. Methods in Molecular Biology, vol 2445. Humana, New York, NY. https://doi.org/10.1007/978-1-0716-2071-7_17
Download citation
DOI: https://doi.org/10.1007/978-1-0716-2071-7_17
Published:
Publisher Name: Humana, New York, NY
Print ISBN: 978-1-0716-2070-0
Online ISBN: 978-1-0716-2071-7
eBook Packages: Springer Protocols